VICO Therapeutics B.V.
Entity

  • VICO Therapeutics B.V.

    Created in 2019
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups

  • Social networks

    3,140

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Biopartner gebouw 1, J.H. Oortweg 21, 2333 CH Leiden, Netherlands

    Leiden

    Netherlands

  • Employees

    Scale: 11-50

    Estimated: 40

  • Engaged corporates

    0
    0 0

  • Added in Motherbase

    9 months ago
Description
  • Value proposition

    Our mission is simple... bring innovative RNA modulating therapies to patients with severe, genetic neurological diseases.

    Vico Therapeutics is committed to advancing RNA modulating therapies for patients with severe, genetic neurological disorders. Vico is initially targeting spinocerebellar ataxia types 3 and 1 and Huntington’s disease. Our VICOMER platform designs antisense oligonucleotides for various genetic defects by modulating or editing RNA. For more information, visit www.vicotx.com

Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Last news
Show all articles
Social network dynamics